AMETEK Announces Appointment of Suzanne Stefany to Board of Directors

Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has appointed Suzanne Stefany as a new director of the Company. Ms. Stefany is a Partner at PJT Partners, an investment bank headquartered in New York City, where she serves as an advisor to leading global multi-industry companies, advising, and executing [...]

Micromeritics Invests to Support Growing Customer Base in Asia

Norcross, Georgia, USA. – Micromeritics announced three significant new investments to support fast-growing APAC markets. The company established direct sales, service, and support operations in South Korea through the acquisition of Protech Korea, its long-time distributor. The new Micromeritics Korea is headquartered in Daejeon, a center for both academic and industrial innovation. Protech has effectively established [...]

UgenTec Joins the Tetra Partner Network To Help Customers Accelerate Scientific Outcomes in Molecular Workflows Using Tetra Data

BOSTON, Mass. – TetraScience, the Scientific Data Cloud company, announced today that UgenTec, a leading molecular laboratory software provider, has joined the Tetra Partner Network so that scientists can use Tetra Data to accelerate automation and scientific insights in molecular labs where enormous amounts of data are generated and analyzed. “UgenTec’s solution solves multiple critical [...]

Thermo Fisher Scientific Introduces Highly Sensitive Research Assays for Measurable Residual Disease Detection in Myeloid Malignancies

Ion Torrent Oncomine Myeloid MRD Assays (RUO) are the first NGS-based tests to offer simultaneous DNA and RNA analysis for myeloid MRD assessment CARLSBAD, Calif., August 04, 2022 - Thermo Fisher Scientific today launched a next-generation sequencing (NGS)-based assay for research in myeloid measurable residual disease (MRD). As the first NGS-based tests to support both DNA [...]

Genovis AB enters service agreement with evitria AG for fast LC-MS analysis of recombinant antibodies

Genovis AB and evitria AG today signed a service agreement to offer evitria’s customers fast LC-MS characterization of recombinant antibodies using Genovis proprietary enzyme technologies. evitria AG is a world leading service With this new service agreement, Genovis expands into a new business area that combines the ease of use of the SmartEnzymesTM with the competence [...]

Illumina Ventures Announces Expansion of its Europe Team

Company sharpens its focus on the European market by bolstering its team and building upon its successes with existing portfolio companies in Europe.  Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, today announced the addition of four new members to its European team. Arnaud Autret, PhD, MSc, will be Principal and [...]

GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution

CAMBRIDGE, England -- Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution. Alistair Johnson is Chief Professional Services Officer at Congenica (Photo: Business Wire) Driven by the increasing adoption of [...]

Copia Scientific Announces the Acquisition of Atlantic Lab Equipment

Nation's largest reseller and service company of certified pre-owned automation and imaging lab equipment acquires Atlantic Lab Equipment of Beverly, Ma. TAUNTON, Mass. - Copia Scientific, LLC, has acquired Atlantic Lab Equipment (originally formed in 2002). With the addition of Atlantic Lab Equipment, Copia has expanded its ability to supply, service, and refurbish automation and [...]

Berkeley Lights and the Jaime Leandro Foundation Announce the Discovery, Functional Characterization, and Recovery of a Patient-Derived T cell Receptor Sequence Against a Cancer Neoantigen

EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and the Jaime Leandro Foundation for Therapeutic Cancer Vaccines (JLF), today announced the discovery, functional characterization, and recovery of a patient-derived T cell receptor sequence against a cancer neoantigen. Together, Berkeley Lights and JLF were able to measure and identify T cells [...]

BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN

MINNEAPOLIS -- Bio-Teche Corporation (NASDAQ: TECH) today announced Chuck Kummeth's planned two-year transition from his position as Bio-Techne's Chief Executive Officer (CEO) effective June 30, 2024. The Company's Board of Directors has begun its search for Mr. Kummeth's replacement, evaluating both internal and external candidates to assume the CEO position upon Kummeth's retirement at the end of [...]

Access IBO on Knowledge Center